IP Library Granted Patent US 10,709,710
Granted Patent B2
US 10,709,710 · App. 15/752,363 · Granted Jul 14, 2020

Composition comprising uric acid for the treatment treated with mechanical thrombectomy

Inventor: Angel Chamorro Sanchez (Barcelona, ES)
Assignees: HOSPITAL CLINIC DE BARCELONA; INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUSTI PI I SUNYER (IDIBAPS)
A61K31/522A61K9/0019A61P25/00A61K31/7068A61K38/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,709,710
App. No.
15/752,363
Granted
Jul 14, 2020
Kind
B2
Abstract

The present invention refers to a composition comprising uric acid for its use in the treatment of brain stroke in a patient treated by means of mechanical thrombectomy.

Claims (16)

1. A method for the treatment of a patient suffering brain stroke comprising:

administering a composition comprising uric acid; and

carrying out a mechanical thrombectomy procedure before, during or after a time for the administration of the composition comprising uric acid has elapsed,

wherein the treatment provides for synergistic effect in the treatment for brain stroke.

2. The method in accordance with claim 1 , wherein the brain stroke is an ischemic brain stroke.

3. The method in accordance with claim 1 , wherein the composition comprising uric acid is used in combination with a composition comprising a thrombolytic agent.

4. The method in accordance with claim 3 , wherein the thrombolytic agent is alteplase.

5. The method in accordance with claim 1 , wherein the composition comprising uric acid additionally comprises citicoline.

6. The method in accordance with claim 1 , wherein the dose of uric acid is between 250 mg and 1250 mg.

7. The method in accordance with claim 6 , wherein the dose of uric acid is 1000 mg.

8. The method in accordance with claim 1 , wherein the uric acid concentration in the composition is between 1 mg/ml and 4 mg/ml.

9. The method in accordance with claim 8 , wherein the concentration of uric acid in the composition is 2 mg/ml.

10. The method in accordance with claim 1 , wherein the composition comprising uric acid is administered intravenously.

11. The method in accordance with claim 1 , wherein the time for the administration of the composition comprising uric acid is 90 minutes.

12. The method in accordance with claim 3 , wherein the step of administering the thrombolytic agent is carried out within about 4.5 hours following the brain stroke.

13. The method in accordance with claim 1 , wherein prior to administering the composition comprising uric acid, a thrombolytic agent is administered.

Assignments (2)
MERGER Recorded Aug 7, 2023
From: CONSORCI INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
To: FUNDACIO DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
Reel/Frame 064512/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2018
From: CHAMORRO SANCHEZ, ANGEL
To: HOSPITAL CLINIC DE BARCELONA; INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUSTI PI I SUNYER (IDIBAPS)
Reel/Frame 044911/0297 →
Continuity (1)
Related Publication 20200009150A1 · Jan 9, 2020